The nasal spray offers the same medical results as the auto-injectors, but it has some other advantages, Lieberman said. If you want to buy the nasal spray without insurance, a two-pack is about ...

The newly approved dosage of epinephrine nasal spray, Neffy, is geared toward children as young as 4-years-old. Skip to content. All Sections. 65°F. Friday, May 30th 2025 e-Edition.

The FDA has approved Neffy, a needle-free nasal spray, for children aged 4 and up, providing fast and effective treatment for severe allergic reactions and anaphylaxis. Skip to main content .

The FDA has approved neffy 1 mg epinephrine nasal spray for treating anaphylaxis and other type 1 allergic reactions in children aged 4 years and older, according to a press release from ARS Pharma.

Johnson & Johnson's Spravato nasal spray has been FDA-approved as a stand-alone therapy for adults with treatment-resistant depression. This marks a significant advancement in depression treatment ...

The FDA has approved a new flu vaccine nasal spray for at-home use. While this self-administered version won't be available for this year's flu season, interest in nasal spray products is growing.

But that could all change soon. The FDA has approved a nasal spray, called neffy, for adults and children who weigh at least 66 pounds. The treatment, which is made by ARS Pharmaceuticals, is ...

It can treat adults and children weighing at least 30 kg, but a version for smaller children is still under review. EU regulators recommended the nasal spray for approval in June.

The first nasal spray for emergency treatment of type 1 allergic reactions, including anaphylaxis, in adults and in children who weigh at least 30 kilograms was approved by FDA on Aug. 9, 2024 (1,2).

The epinephrine nasal spray, called Neffy, offers an alternative to EpiPen injections and is approved for adults and children who weigh at least 30 kilograms (about 66 pounds), said the FDA in a ...